Most Read Articles
Pearl Toh, 10 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 16 Jan 2018
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
3 days ago
Rates of immunization particularly in a primary care setting can be improved by constant patient reminders and recall systems, a recent study has found.
4 days ago
It appears that urgent repeat endoscopic retrograde cholangiopancreatography (ERCP) predicts failure of plastic stent treatment for biliary strictures (BS) following liver transplant, according to a study.

Product Highlight - Natrixam

27 May 2016
NATRIXAM – Indapamide, amlodipine 1.5 mg/5 mg and 1.5 mg/10 mg MR tab – Servier
  • Natrixam 1.5 mg/5 mg contains indapamide SR 1.5 mg and amlodipine 5 mg
  • Natrixam 1.5 mg/10 mg contains indapamide SR 1.5 mg and amlodipine 10 mg
  • Reduced BP effectively in patients who were previously uncontrolled on CCB monotherapy1,2
  • Reduced BP effectively in untreated with grade 2 or 3 patients1,2
  • Strong efficacy for SBP with a ∆SBP/∆DBP ratio of 1.821,2
  • Safe and well tolerated1,2 

References: 
1. Jadhav U et al. PLOS One. 2014;4;e92955. 
2. Safar M et al. Am J Cardiovasc Drugs. 2014;14(6):423-432.

Further information is available in Section 2e, 2h, New In This Issue and mims.com.
Full prescribing information is available upon request. 16 NM 001 IA MAL

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 10 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 16 Jan 2018
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
3 days ago
Rates of immunization particularly in a primary care setting can be improved by constant patient reminders and recall systems, a recent study has found.
4 days ago
It appears that urgent repeat endoscopic retrograde cholangiopancreatography (ERCP) predicts failure of plastic stent treatment for biliary strictures (BS) following liver transplant, according to a study.